2 Patients must have histologically proven low grade astrocytoma anaplastic astrocytoma anaplastic mixed glioma anaplastic oligodendroglioma glioblastoma multiforme astrocytoma WHO II oligodendroglioma WHO II or mixed glioma WHO II Patients do not haveto demonstrate progressive disease to participate in this study 